Search tips
Search criteria 


Logo of transmedBioMed CentralBiomed Central Web Sitesearchsubmit a manuscriptregisterthis articleJournal of Translational MedicineJournal Front Page
J Transl Med. 2010; 8(Suppl 1): I12.
Published online 2010 November 25. doi:  10.1186/1479-5876-8-S1-I12
PMCID: PMC3007730

Early-onset inflammatory bowel disease caused by mutant IL10 receptor


The molecular etiology of inflammatory bowel diseases (IBD) is largely unknown.


We performed genetic linkage analysis and candidate gene sequencing in two unrelated consanguineous families with children affected by early-onset IBD. We screened six additional patients for mutations in two candidate genes and carried out functional assays in patients’ peripheral blood mononuclear cells. We treated one patient with an allogeneic hematopoietic stem cell transplant (HSCT).


We identified three distinct homozygous mutations in the genes IL10RA and IL10RB, encoding the IL10R1 and IL10R2 proteins, respectively (which form a heteromer to make up the interleukin-10 receptor) in four of nine patients with early-onset colitis. The mutations abrogate IL10-induced signaling, as demonstrated by deficient STAT3 phosphorylation upon IL10 stimulation. Consistent with this observation is the increased secretion of TNFα and other proinflammatory cytokines from peripheral blood mononuclear cells from IL10R-deficient patients, suggesting that IL10-dependent “negative feedback” regulation is disrupted in these cells. One patient was successfully treated by an allogeneic HSCT.


Mutations in genes encoding the IL10R subunit proteins cause human enterocolitis, involving hyperinflammatory immune responses in the intestine. Allogeneic HSCT may offer a cure for IL10 receptor deficiency.

Articles from Journal of Translational Medicine are provided here courtesy of BioMed Central